Success Metrics

Clinical Success Rate
92.5%

Based on 74 completed trials

Completion Rate
93%(74/80)
Active Trials
27(20%)
Results Posted
35%(26 trials)
Terminated
6(4%)

Phase Distribution

Ph phase_4
7
5%
Ph phase_3
17
13%
Ph not_applicable
42
31%
Ph phase_2
36
27%
Ph early_phase_1
4
3%
Ph phase_1
28
21%

Phase Distribution

32

Early Stage

36

Mid Stage

24

Late Stage

Phase Distribution134 total trials
Early Phase 1First-in-human
4(3.0%)
Phase 1Safety & dosage
28(20.9%)
Phase 2Efficacy & side effects
36(26.9%)
Phase 3Large-scale testing
17(12.7%)
Phase 4Post-market surveillance
7(5.2%)
N/ANon-phased studies
42(31.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.4%

74 of 81 finished

Non-Completion Rate

8.6%

7 ended early

Currently Active

27

trials recruiting

Total Trials

134

all time

Status Distribution
Active(33)
Completed(74)
Terminated(7)
Other(20)

Detailed Status

Completed74
Recruiting22
unknown20
Not yet recruiting6
Terminated6
Active, not recruiting5

Development Timeline

Analytics

Development Status

Total Trials
134
Active
27
Success Rate
92.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (3.0%)
Phase 128 (20.9%)
Phase 236 (26.9%)
Phase 317 (12.7%)
Phase 47 (5.2%)
N/A42 (31.3%)

Trials by Status

not_yet_recruiting64%
completed7455%
recruiting2216%
terminated64%
withdrawn11%
unknown2015%
active_not_recruiting54%

Recent Activity

Clinical Trials (134)

Showing 20 of 134 trialsScroll for more
NCT06638502Phase 1

Safety of HRX215 in Patients After Minor and Major Liver Resection

Recruiting
NCT06649981Phase 1

Aging Resilience Through Microbiota Optimization and Regulation

Active Not Recruiting
NCT04734106Early Phase 1

Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis

Recruiting
NCT01631617Phase 2

Effects of Treatments on Atopic Dermatitis

Recruiting
NCT07282821Phase 2

Bempedoic Acid Therapy for Polycystic Kidney Disease

Not Yet Recruiting
NCT07691749Not Applicable

Effect of Psychobiotics With Standard Antiddepressants in Treatment of Major Depressive Disorder

Recruiting
NCT07713641Not Applicable

Short-Chain Fatty Acids in Lypopolysaccharide-Induced Inflammation and Executive Function

Recruiting
NCT05548452Phase 1

Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease

Recruiting
NCT06747611Phase 2

Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata

Recruiting
NCT07106580Phase 1

Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Via Capsules for Intestinal Multidrug-resistant Bacteria Decolonization

Recruiting
NCT07639177Phase 2

Faecal Microbiota Transplantation in Patients With Refractory Rheumatoid Arthritis

Not Yet Recruiting
NCT07628777Phase 1

Fecal Microbiota Transplantation for Elderly Patients With HFpEF: A Randomized Controlled Trial

Not Yet Recruiting
NCT06017609Phase 2

Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction

Completed
NCT07219498Not Applicable

Effects of a 5-Week Probiotic Supplementation Intervention on Markers of Delayed Onset Muscle Soreness

Recruiting
NCT07076849Phase 2

Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females

Recruiting
NCT07415720Not Applicable

Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention.

Recruiting
NCT04685590Phase 2

Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study

Active Not Recruiting
NCT04580472Phase 4

Utility of Single-dose Oral Antibiotic Prophylaxis in Prevention of Surgical Site Infection in Dermatologic Surgery

Active Not Recruiting
NCT07484412Not Applicable

Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms

Active Not Recruiting
NCT07052890Not Applicable

Curcumin, Vitamin D and Green Tea in IBS-D

Completed

Drug Details

Intervention Type
DRUG
Total Trials
134